Catalyst MedTech and Arineta: Partnership Boosts Cardiac CT Innovations Across the U.S.

Catalyst MedTech Expands Partnership with Arineta

Catalyst MedTech, an industry leader in diagnostic imaging, recently announced a significant expansion of its collaboration with Arineta, renowned for its advanced cardiovascular imaging solutions. This strategic move is poised to not only boost the sales of Arineta’s cutting-edge SpotLight™ CT systems within the U.S. market but also to energize the cardiac CT landscape overall.

A Deeper Relationship

Over the past two years, Catalyst has been an integral partner, providing installation and service support for Arineta’s innovative single-beat cardiac CT technology. The enhanced partnership now positions Catalyst as both a commercial and technical ally for Arineta, highlighting a commitment to driving growth in North America. This collaboration aims to leverage Catalyst's extensive market knowledge and sales infrastructure to significantly amplify Arineta’s market presence.

Martin Shirley, the President and CEO of Catalyst MedTech, expressed enthusiasm over this expanded relationship, stating, "At Catalyst, we don’t just maintain technology—we accelerate it." He emphasized the firm’s role in helping Original Equipment Manufacturers (OEMs) unlock new market potential. By harnessing their extensive sales expertise and knowledge of the cardiology market, Catalyst aims to streamline the introduction of Arineta’s revolutionary products to a broader audience.

Market Demand and Technological Innovation

Arineta’s expansive vision is to enhance accessibility to vital cardiovascular imaging. Doug Ryan, the CEO of Arineta, underscored the company's commitment to expanding their offerings, stating, "Catalyst has been a trusted partner in our journey. This strategic move enables us to cater to the increasing demand for cardiac CT technology more effectively." The partnership will facilitate a comprehensive support network tailored to meet the needs of health systems and imaging centers.

Arineta's SpotLight™ and SpotLight™ Duo scanners are recognized for their advanced single-heartbeat cardiac CT angiography technology, offering high-resolution imaging with low radiation doses, thus improving patient comfort and care. This technological innovation aligns seamlessly with Catalyst’s ethos of enabling advanced diagnostics in cardiology.

Transforming the Landscape of Cardiac Imaging

With this partnership, Catalyst is positioned to play a pivotal role in the growth of the cardiovascular imaging market. The integrated approach will enable Catalyst not just to support existing customer opportunities, but also to explore new sales channels, thereby expanding their reach in this vital sector of healthcare technology. The ultimate goal is to enhance access to state-of-the-art cardiac imaging, currently crucial for patient diagnosis and treatment.

The Propel Partner Program serves as a model for how such collaborations can help OEMs realize their growth potential in the competitive U.S. market by providing invaluable sales momentum and access to key market segments. Shirley concluded, "We see ourselves as the catalyst for progress in diagnostic imaging, delivering value, accessibility, and acceleration for our partners and customers."

For more information about Catalyst MedTech's Propel Partner Program or to learn more about Arineta’s cutting-edge cardiac CT solutions, interested parties can visit Catalyst MedTech and Arineta.

About Catalyst MedTech

Catalyst MedTech stands as a national provider of advanced diagnostic imaging solutions, focusing on nuclear medicine, molecular imaging, and CT. Armed with specially trained teams and ISO-certified service operations, the company emphasizes empowering healthcare providers and OEM partners to innovate effectively in imaging technology.

About Arineta

Headquartered in Caesarea, Israel, Arineta is dedicated to developing groundbreaking single-heartbeat cardiac CT systems that prioritize high-resolution imaging while minimizing patient exposure to radiation. Their mission centers on pushing the boundaries of cardiovascular care through technological advancements.